Market revenue in 2023 | USD 5.7 million |
Market revenue in 2030 | USD 10.3 million |
Growth rate | 8.9% (CAGR from 2023 to 2030) |
Largest segment | Dual channel |
Fastest growing segment | Single Channel |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Channel, Dual Channel |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dual channel was the largest segment with a revenue share of 57.89% in 2023. Horizon Databook has segmented the Chile deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
High prevalence of mental disorders in Chile is a major factor driving the market growth over the forecast period. However, low healthcare expenditure in the country often restricts entry of new or local players in the market, as the scope for growth is very limited. Furthermore, limited number of hospitals and clinics in Chile is expected to lower the demand for deep brain stimulation devices.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account